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Specificity of the Effects of Lead on
Brain Energy Metabolism for
Substrates Donating a Cytoplasmic
Reducing Equivalent
by R. J. Bull,* P. M. Stanaszek,' J. J. O'Neill,t and S. D.
Lutkenhoff*
Lead chloride, at concentrations of 67 ,uM in the incubation media, inhibits the
potassium-stimulated respiration (3 to 30mM increase in K+) of rat cerebral cortex slices.
The inhibition observed was dependent upon the substrate provided. In the presence of
10mM glucose or lactate, 35-50% inhibition of the response was observed, but no evidence
of an effect could be observed when 10mM pyruvate served as substrate. In consonance
with these observations, spectral measurements during the course of the response
revealed an attenuation of the initial NAD(P)H oxidation followed by a substantial ac-
cumulation of the intermediate in slices metabolizing glucose, but not those metabolizing
pyruvate. In vivo treatment of adult rats with six intraperitoneal injections spaced over a
14-day period gave rise to essentially similar findings at cerebral cortical lead concentra-
tions averaging 0.41 ,ug/g (range = 0.34-0.52) and above. No effect was observed at brain
lead concentrations averaging 0.17,tg/g.
These data suggested that lead interfered with the oxidation ofthe NAD(P)H produced
by the initial oxidations ofglucose inthe cytoplasm. Inhibition ofcytoplasmic NAD(P)H ox-
idation by brain mitochondria is of peculiar importance in a tissue relying almost ex-
clusively upon the metabolism of glucose in vivo.
Introduction
The picture developed in animal models of lead
encephalopathy involves a primary lesion in
cerebellar capillaries which is followed by
degenerative changes in astrocytic foot processes
and then neuronal degeneration (1). This sequence
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ofevents is taken to indicate that alterations ofthe
blood-brain barrier to lead is the initial insult in
the development of lesions in young animals.
However, as Michaelson and Sauerhoff (2) have
pointed out, the production of these changes re-
quires very high doses of lead and results in gross
abnormalities of nervous system function. This
grosspathologyprobably obscuresthe development
of more subtle functional changes such as the re-
cently documented behavioral changes which have
an intriguing resemblance to hyperkinesis in
children both symptomatically and phar-
December 1975 89macologically (2, 3). These latter changes are ob-
served without evidence of gross histopathology.
In the same light, it would seem that the rarity
of lead encephalopathy in lead-exposed adults
(either animal or man) does not state with any cer-
tainty the lack of lead effect on higher functions of
the nervous system. These effects would be very
difficult to assess in individual patients because of
the inability to generate a proper control or normal
value. Consequently, we feel that the so-called in-
senitivity of the adult brain to the effects of lead
needs re-examination. This is particularly impor-
tant when the much longer period oflead exposure
as an adult is taken into account and the fact that
lead encephalopathy in the child really involves
acute or at least subacute exposures to very high
doses of lead.
In order to immediately address the question as
to the inherent sensitivity ofadult rat brain to lead,
we have utilized a spaced intraperitoneal (IP) in-
jection schedule. We judged the relevance of our
data on the basis of the lead concentration
achieved in brain at the end of the treatment
period. This is basically to avoid the problem ofthe
very low absorption rate of lead from the gastroin-
testional tract. Secondly, we have chosen a general
model ofCNS function which we feel avoids the in-
terpretive problems of extrapolating behavioral
measurements in animals to man. While the model
has the disadvantage ofnotproducing data directly
translatable into functionalities at the whole ani-
mallevel,itdoesunquestionablyaddresstheproper-
ties of brain which are basic to these functions.
Methods
Male Sprague-Dawley rats (200-400 g) were ex-
posed to PbCl2 dissolved in distilled water by the
intraperitoneal route over a 2-week period. The
total doses administered for the period were 3, 12,
and 60 mg Pb/kg body weight in six evenly divided
doses. The volume of the injection was 2.0 ml/kg.
Controls were injected at the same frequency with
an equivalent volume of distilled water. Animals
were sacrificed 2 days following the final injection.
Slices were prepared from the outer layer of the
cerebral cortex and incubated as previously
described (4).
The incubation media consisted of NaCl,
127mM; MgCl2, 1.3mM; NaH2PO4, 1.3mM; KCl,
3.0mM; CaCl2, 0.75mM, plus glucose, lactate or
pyruvate at a concentration of lmM and either
NaHCO3, 26mM, or glycylglycine, 30mM, as buffer.
The media was continually saturated with 95%
02/5% C02 when bicarbonate served as buffer and
100% 02 when glycylglycine was used. The pH of
the media was 7.4. Tissues were incubated under
the superfusion conditions routinely employed in
our laboratory (4).
After a 30-min preincubation period, the media
potassium concentration was increased from 3 to
30mM. Spectral, oxygen uptake and lactic acid
measurements were made as previously described
(4, 5).
In vitro experiments were conducted similarly.
Lead was introduced, as the chloride, 20 min prior
to the addition of potassium.
Lead determinations were made in a separate
group of animals exposed to the same IP injection
schedule described above. Flameless atomic ab-
sorption spectrophotometry employing a graphite
furnace was used for the analysis following
solubilization of the tissue with 1.0 ml 24%
tetramethylammonium hydroxide in methanol.
Some difficulties were encountered in obtaining
consistent recoveries from lead-treated animals so
the method of standard additions was employed.
Full details of the method will be published
elsewhere (Ulmer, in preparation).
Results
As a means ofestimating the gross toxicity ofthe
IP injection schedule used to expose animals to
lead, body weight of the animals were periodically
measured. These results are shown in Figure 1.
Only atthe highest dose used, 60 mg/kg total for the
14-day period, was there any marked effect on body
weight gain of young adult rats. Even in this case,
the effect appeared to be temporary. After a 4-5
day lag, animals on this dose began to gain weight
at a rate parallel to control animals, despite the
continued administration of lead.
Cerebral cortex slices taken from lead-exposed
animals were observed to show marked changes in
their metabolic responses to an increase in media
potassium concentration from 3 to 30mM. This was
particularly evident in spectral measurements of
tissue NAD(P)H* (Fig. 2) when 10mM glucose
served as substrate. Lead was seen to shorten the
normal oxidative phase of the NAD(P)H response
and markedly to enhance both the rate and extent
of NAD(P) reduction in the second phase of the
response. The rate at which this latter effect
*The term NAD(P)H is used to refer to both NADH and
NADPH sincetheycannotbe differentiated spectrally. The bulk
of the evidence available would imply that the changes ob-
served involve principally NADH, but this cannot be taken as
conclusively established.
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FIGURE 2. Effect of Pb on potassium-induced redox changes of
NAD(P)H in cerebral cortex slices taken from exposed
animals. HCO3/CO2 media was utilized with glucose as
substrate. Same dosage schedule as in Fig. 1; 27 mM
potassium added at zero time. Curves derived from the
average of not less than six animals ± SEM.
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FIGURE 1. Gross toxicity of the IP injection schedule used for
administration of Pb as measured by body weight gain.
Total doses indicated were administered in six equally
divided doses over the 2-week period. Each group consisted
of six animals and average values are indicated ± SEM.
developed in the response shows a clear relation-
ship with the dose oflead, although the net increase
in NAD(P)H was not substantially different at
total doses of 12 and 60 mg/kg body weight. There
was no suggestion ofthe effect at 3.0 mg Pb/kg. The
comparability ofthe tissues used in these measure-
ments was judged by the initial absorbance of
cytochrome c + ci (550-540 nm). This value has
been previously established to represent more than
90% ofthe total cytochrome c in the tissue (5). The
valuesthus obtained were: control, 0.0140 ± 0.0009
O.D. units (± SEM of ten tissues); 3 mg/kg, 0.0148
+ 0.0014 (six tissues); 12 mg/kg, 0.0146 + 0.0013
(seven tissues); and 60 mg/kg, 0.0148 0.0008
(seven tissues).
Figure 3 illustrates the change induced in the
respiratory responses of cerebral cortex slices by
treatment of animals with a total dose of 60 mg
Pb/kg. In confirmation of the spectral measure-
ments, an inhibition of potassium-induced respira-
tion was observed. It was interesting to note that
the inhibition showed some specificity for the
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FIGURE 3. Potassium-induced respiratory changes in cerebral
cortex slices taken from animals exposed to Pb. Same condi-
tions as in Fig. 2. Each curve is an average derived from at
least 15 animals and expressed ± SEM.
declining phase ofthe response, the peak rate show-
ing little change from control tissues. The rates
measured at 2 and 3 min following addition of
potassium were statistically different from control
(p < 0.05), whereas other values were nonsignifi-
cant (p > 0.05). Lead treatment appeared to have
no effect upon the nonstimulated rate of respira-
tion (1.63 ± 0.19 ,tmole/g min for control tissues
and 1.60 ± 0.31 for tissues taken from lead-exposed
animals).
Despite the apparent increased level of reduc-
tion of tissue pyridine nucleotides, neither
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91unstimulated or stimulated rates of aerobic
glycolysis were significantly increased by the lead
treatment (Fig. 4). In fact, a small statistically in-
significant decrease in the stimulated lactic acid
output by the tissues was observed following lead
treatment.
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FIGURE 4. Responses of the aerobic glycolytic rate to
potassium in cerebral cortex slices taken from Pb-exposed
animals. Same conditions as in Fig. 2. Each curve represents
the average ofnot less than 6 animals. Vertical bars indicate
± SEM.
The effects of lead on the metabolic responses of
tissues taken from exposed animals could be
largely reproduced in vitro. For these experiments
its was necessary to change to a glycylglycine
buffered incubation media, since lead salts were in-
soluble in the bicarbonate buffer ordinarily used.
This resulted in substantial changes in the spectral
responses and measured rates of aerobic glycolysis
(compare Figs. 2, 4, and 5). These alterations are
attributable primarily to the removal of
HCO3/CO2 from the media rather than a toxic
effect of glycylglycine (R. J. Bull, unpublished
results).
Figure 5 shows the results obtained from tissues
utilizing glucose as substrate when exposed to
67,uM PbCl2 20 min prior to stimulation by
potassium. Despite the fact that the reduction of
NAD(P) was substantially reduced in the
glycylglycine buffer, inclusion oflead in the incuba-
tion media resulted in an increased level of
NAD(P)H following potassium relative to control.
PbCl2 at a concentration of 25,uM was without
effect. In contrast to the results obtained from
tissues taken from exposed animals, a small but
significant reduction in both nonstimulated and
potassium-stimulated aerobic glycolysis was ob-
served with lead, in vitro. The burst of respiration
induced by the 3 to 30mM increase in media
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FIGURE 5. Effect on Pb, in vitro, on the metabolic responses of
rat cerebral cortex slices to elecated potassium concentra-
tions. Glucose as substrate, glycylglycine buffer: (top)
NAD(P)H redox state; (center) aerobic glycolysis; (bottom)
oxygen consumption. Each curve represents the average of
not less than five tissues. Vertical bars indicate ± SEM.
potassium concentration was inhibited by approx-
imately 50% by 67 ,uM PbCl2. Little specificity was
noted for the declining phase of the response.
The effect of lead on the metabolic responses
was essentially absent in cortical slices metaboliz-
ing pyruvate (Fig. 6). A small inhibition of the in-
itial oxidation of NAD(P)H was noted, but there
was no sign of the enhanced reduction of NAD(P)
in the second phase of the response. Potassium-
stimulated respiration of slices metabolizing pyru-
vate in the presence of67 ,M PbCl2 was not altered
from control.
When lactate, 10mM, was utilized as substrate
the potassium-induced respiratory burst was in-
hibited by 67 ,uM PbCl2 (Fig. 7). The inhibition ob-
served was approximately 30-35% during the peak
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92of the response. Again, little specificity was noted
for any particular portion of the response.
The specificity of the lead effect for substrates
donating a cytoplasmic reducing equivalent could
also be demonstrated in tissues taken from lead-ex-
posed animals. If pyruvate served as substrate, no
significant alterations in the potassium-induced
respiratory burst could be demonstrated as a total
dose of 60 mg Pb/kg (Fig. 8).
Lead concentrations measured in whole blood
and cerebral cortex ofrats subjected to the IP injec-
tion sched-lue-are shown in Table 1. Both the levels
in blood and brain were found to increase in a man-
ner directly dependent upon dosage. The con-
centrations of lead in blood were quite variable,
particularly,at the 60 mg/kg dose. Iftwo samples of
about 1000 /itg/100 ml are excluded from this
group, the remaining four animals averaged ap-
proximately 100/.tg/100 ml. The great variability of
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FIGURE 6. Effect of Pb, in vitro, on potassium-induced
metabolic changes in rat cerebral cortex slices utilizing pyru-
vate as substrate. (top) NAD(P)H redox state; (bottom) ox-
ygen consumption. Each curve represents the average of at
least five tissues. Vertical bars indicate ± SEM.
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FIGURE 8. Respiratory responses of cerebral cortex slices,
taken from animals exposed to Pb, to elevated potassium
concentration when utilizing pyruvate as substrate. Same
dosage schedule and conditions as utilized in Fig. 2. Each
curve represents the average for at least six animals ± SEM.
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FIGURE 7. Effect of Pb, in vitro, on potassium-induced respira-
tion in cerebral cortex slices utilizing lactate as substrate.
Curves describe average results from at least 5 tissues. Verti-
cal bars indicate ± SEM.
Table 1. Lead concentrations in blood and brain follow-
ing a 2-week, I.P. injection schedule.
Pb in blood, ,ug/100mla Pb in cerebral cortex,
pg/ga
Dose, mg/kg Avg. Range Avg. Range
Control 0.8 < 0.5 - 2.0 0.06 0.04 - 0.10
3.0 13.2 10.0 - 17.5 0.17 0.10 - 0.24
12.0 72.6 32.0 - 126 0.41 0.34 - 0.52
60 380 60 - 1040 1.02 0.48 - 1.78
an = 6
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93blood concentrations of lead in this group was un-
doubtedly attributable to the tendency of lead,
given in this dosage range, to precipitate in the
peritoneal cavity, thus retarding systemic absorp-
tion. Cerebral cortical lead concentrations were
also variable in this group, and an apparent rela-
tionship existed between unusually high blood
level and higher concentrations in this tissue.
However, too few samples were available for
detailed analysis.
Discussion
To our knowledge, the present work represented
the first attempt to document the effects of lead on
energy metabolism of brain in a dynamic state.
Cerebral cortex slices were induced to perform
osmotic work in response to a change in media
potassium concentration. The osmotic work cannot
be exclusively attributed to transport ofpotassium,
since calcium movements have also been impli-
cated (6). Signs of an immediate energy demand
were quickly followed by the reinstitution of
metabolic control and the establishment of a new
steady state characterized by recovery of ATP and
phosphocreatine concentrations, slowing ofthe rate
of respiration and reduction ofthe respiratory car-
riers (4, 5). It should be noted that rat brain has
been estimated to respire atrates of4.9,umole O2/g-
minin vivo (7). In the isolated tissues utilized in the
present study, such rates are approached only dur-
ing the peak ofthe respiratory burst (1.6 basal plus
2.0 ,umole/g-min during peak response). Therefore,
the measured rates are completely reasonable in
terms ofthe normal energy demand ofthe tissue, in
viVo.
Previous work by Cremer (8-11) revealed a
similar substrate selectivity for respiration sup-
ported by glucose in brain tissue ofrats exposed to
triethyltin and triethyllead. Both compounds in-
hibited 14CO2 production from radiolabeled
glucose but not from pyruvate in rat cortical slices.
However, Cremer indicated that an increase in the
rate oflactic acid production by brain slices accom-
panies the inhibition of glucose-supported respira-
tion. This was not observed in the present work,
although a substantial increase in tissue NAD(P)H
was observed to occur following addition of
potassium. Despite this difference, our data do
strongly implicate an inhibition ofthe oxidation of
reducing equivalents produced in the cytosol. This
was the same explanation offered by Cremer for her
results with organic lead and tin. Apparently, the
increased NAD(P)H observed with inorganic lead
is no longer simply associated with the cytoplasm,
since it did not appear available for reduction of
pyruvate to lactate. An alternate explanation is
that pyruvate concentrations become limiting in
our system as a result ofincreased Kreb's cycle ox-
idation and the huge sink for lactate produced by
tissue superfusion. In either case, the increased
NAD(P)H following addition ofpotassium must be
derived from cytoplasmic oxidations in order to ex-
plain the differential effects of lead on glucose and
pyruvate supported respiration within the frame-
work of our present understanding of the inter-
mediary metabolism of mammalian brain. That
the inhibition of respiration observed was
specifically associated with utilization of
cytoplasmic reducing equivalents appears amply
demonstrated by the results obtained with lactate
serving as substrate. The only known pathway for
lactate oxidation is through its conversion to pyru-
vate resulting in the production of 1 mole of
NADH/mole of lactate oxidized.
In terms of the effects of lead on isolated
mitochondria, there seems to be no easily discerned
precedent for the specificity for the oxidation of
cytosolic reducing equivalents. There seems to be
general agreement that tissue pyridine nucleotides
do not pass through the mitochondrial membrane
and NADH reduced in the cytosol must be oxidized
by shuttle mechanisms. Scott et al. (12) have
reported the relative insensitivity of TMPD-ascor-
bate oxidation in isolated heart mitochondria but
inhibition of succinate or NADH coupled respira-
tion. However, in these same studies lead was ob-
served to have various effects upon ion transloca-
tion in mitochondria depending upon the anionic
composition of the media. In many respects, lead
accumulation by mitochondria was found to be
quite similar to the calcium accumulation reac-
tions of isolated mitochondria. The present study
utilized ionic stimulation to activate energy
metabolism of brain slices and little alteration of
metabolism was produced by lead in unstimulated
tissues. This suggests that interactions of lead with
ion transport mechanisms of brain mitochondria
could underlie the effects noted in the present
study. Indeed, calcium, a well-known antagonist of
lead effects both in vitro and in vivo, has been
shown (13) to influence the mitochondrial com-
partmentation of NADH.
We have reported somewhat similar results as
noted here in brain slices taken from rats exposed
to methylmercury (14). Coupled with the observa-
tions of Cremer (8) indicating similar findings with
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brain, but not kidney slices, these data suggest a
mechanism which may be common to heavy metal
derivatives capable ofpenetrating the blood-brain
barrier. Such an effect would explain the apparent
selectivity certain ofthese compounds have for the
central nervous system which is organized to
preferentially utilize glucose as its major energy
source both in vivo and in vitro.
On the basis oflead determinations in brain, the
effect we observe seems relevant to current en-
vironmental exposures to lead. In an autopsy study
involving 150 accident victims, Schroeder and Tip-
ton (15) report an average of 0.1 ,ug Pb/g but a
range of 80% of the samples which would encom-
pass values to 1.4 ,ug/g. On a limited number of
samples, Barry and Mossman (16) reported a simi-
lar average of 0.17 ,ug/g wet weight. However,
Zaworski and Oyasu (17) reported brain levels
averaging 0.5 ,ug/g in a survey of autopsy material
from Chicago hospitals. The sample in this latter
study was the right frontal lobe ofthe cerebral cor-
tex. Levels averaging 0.41 ,ug Pb/g were observed to
result in substantial alterations in the NAD(P)H
response to elevated potassium concentrations in
the present'study. It is interesting to observe that
Michaelson and Sauerhoff (12)reported concentra-
tions of0.5,ug/g in the brains ofyoung rats display-
ing hyperactive behavior. To the extent that our
data may be extrapolated to man, it would seem
that relatively small elevations of brain lead con-
centrations over those encountered under current
environmental conditions may produce biochemi-
cal changes in the brain.
The concentrations of lead required in the in-
cubation media to produce similar effects in vitro
were approximately 30-fold greater than those
found in tissue taken from exposed animals. This
suggests that a 20-min preincubation period in
vitro was insufficient to allow lead to distribute in
the tissue in a way similar to that occurring in vivo.
This perhaps represents a limitation to in vitro ex-
perimentation with inorganic lead.
Atthis point it is not possible to projectthe types
of functional impairment which would result from
such changes at the biochemical level. From what
is known ofbrain metabolism it would be supposed
thatthe effects observed would be quite diverse and
nonspecific in terms ofthe various functions of the
nervous system. This indeed seems to be thepicture.
observed with lead poisoning and has contributed
to the difficulties encountered in attempting to un-
derstand the underlying mechanisms involved (2).
What specificity is observed may depend largely
upon the distribution of lead within the brain and
not to any inherent susceptibility ofparticular cells
ofthe brain. This is actually suggested by observa-
tions concerning the order in which histopathologi-
cal damage develops as the result of high pre- and
postnatal doses of lead (1).
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